Pfizer to Partner with Russia Drugmaker Polysan to Reach Local Market, Sources

Jan. 21, 2016

U.S.-based Pfizer will soon launch a joint production with Russian scientific and technological pharmaceutical company, Polysan, says Russian media sources.

According to TASS news agency, the agreement, which should be signed January 25, involves Pfizer producing its meds in Polysan's St. Petersburg facility.

Polysan is already producing four of its own drugs, as well as a neurological drug in partnership with German Stada, from its Petersburg site.

Read the TASS article